July 2, 2024 BHR Newsletter 1. FTC probes Teva over drug patents Full story 2. Chevron ruling may hinder drug development, experts say Full story 3. Moderna gets $176M to develop mRNA flu shots Full story 4. Turn a crisis…
Pharmacy Report
July 1, 2024 BHR Newsletter 1. Cancer drug shortage ends Full story 2. 10 numbers on prescription drug costs: GoodRx Full story 3. Congress warms to Medicare coverage of weight loss drugs Full story 4. Negotiating with payers can be…
June 27, 2024 BHR Newsletter 1. All 71 CHS hospitals to use Mark Cuban's drug wholesale services Full story 2. 64 drugs getting temporary price cuts Full story 3. Walgreens to close 'significant' number of underperforming stores Full story 4.…
June 26, 2024 BHR Newsletter 1. New drug cuts cardiovascular events, death by 36% Full story 2. Cancer drug shortages 'a moving target,' cancer centers say Full story 3. GLP-1s are reshaping plastic surgery patient demands Full story 4. The…
June 25, 2024 BHR Newsletter 1. Older adults still taking aspirin for heart health despite push to stop Full story 2. Teva launches first generic GLP-1 Full story 3. Intermountain expands pharmacy fulfillment center Full story 4. Documenting and coding…
June 24, 2024 BHR Newsletter 1. AdventHealth launches 1st-of-kind cancer vaccine trial Full story 2. Walgreens pursues provider status for pharmacists Full story 3. Eli Lilly hits phony drugmakers with 6 more lawsuits Full story 4. Some CNOs are gaining…
June 20, 2024 BHR Newsletter 1. 5 drugs now in shortage Full story 2. Insured patients often save less with Mark Cuban's drug company: Study Full story 3. GLP-1s effective at pediatric weight management, BMI reduction Full story 4. How…
June 19, 2024 BHR Newsletter 1. Cancer therapy trials paused after 2 deaths Full story 2. A strategic transition into the C-suite Full story 3. FDA approves 1st adult vaccine for bacterial pneumonia Full story 4. AI is accelerating clinical research…
June 18, 2024 BHR Newsletter 1. Are GLP-1s curbing alcohol, gambling addictions? Full story 2. Digital health executives' arrests could disrupt ADHD treatment, CDC says Full story 3. 340B drug program spending up 19% + 6 other notes Full story…
June 17, 2024 BHR Newsletter 1. Mark Cuban: Pharma has been 'easiest industry' to disrupt Full story 2. New heart disease risk tool finds 40% fewer people need statins: Study Full story 3. FDA again delays Drug Supply Chain Security…